AN ACT TO AUTHORIZE A PHARMACIST TO TEST OR SCREEN FOR AND INITIATE OR ADMINISTER TREATMENT FOR MINOR, NONCHRONIC HEALTH CONDITIONS; TO DEFINE THE TERM "MINOR, NONCHRONIC HEALTH CONDITION"; TO AUTHORIZE A PHARMACIST TO DELEGATE THE ADMINISTRATIVE AND TECHNICAL TASKS OF PERFORMING CERTAIN TESTS TO AN INTERN OR PHARMACY TECHNICIAN ACTING UNDER THE SUPERVISION OF THE PHARMACIST; TO AUTHORIZE A PHARMACIST TO PROHIBIT THE DENIAL OF REIMBURSEMENT UNDER HEALTH BENEFIT PLANS FOR SERVICES AND PROCEDURES PERFORMED BY A PHARMACIST THAT ARE WITHIN THE SCOPE OF THE PHARMACIST'S LICENSE, AND WOULD BE COVERED IF THE SERVICES OR PROCEDURES WERE PERFORMED BY A PHYSICIAN, AN ADVANCED PRACTICE REGISTERED NURSE, OR A PHYSICIAN ASSISTANT; TO AMEND SECTION 73-21-73, MISSISSIPPI CODE OF 1972, TO INCLUDE IN THE DEFINITION OF THE TERM "PRACTICE OF PHARMACY", ORDERING, PERFORMING, AND INTERPRETING CERTAIN TESTS AND INITIATING, ADMINISTERING, OR MODIFYING DRUG THERAPY; TO BRING FORWARD SECTION 83-9-36, MISSISSIPPI CODE OF 1972, WHICH RELATES TO PRESCRIBING PRACTITIONERS, STEP THERAPY OR FAIL-FIRST PROTOCOLS AND OVERRIDE PROCEDURES, FOR THE PURPOSE OF POSSIBLE AMENDMENT; AND FOR RELATED PURPOSES.
Impact
Should this bill pass, it will lead to significant amendments in the Mississippi Code, particularly concerning the practice of pharmacy. Specifically, it will redefine the scope of practice for pharmacists, allowing them to include certain diagnostic and treatment services. The bill also permits pharmacists to delegate administrative and technical tasks related to these health services to pharmacy technicians or interns. Furthermore, the legislation mandates that health benefit plans cannot deny reimbursement for services performed by pharmacists that fall within their licensed scope, which aims to equalize the treatment of pharmacists and other prescribing practitioners in insurance contexts.
Summary
House Bill 533 seeks to expand the role of pharmacists in Mississippi by authorizing them to test for and initiate treatment for minor, nonchronic health conditions. This includes conditions like influenza, urinary tract infections, and COVID-19. The bill provides a definition for 'minor, nonchronic health conditions' and details the specific conditions that pharmacists can manage. By enabling pharmacists to perform these tests and treatments, the bill aims to increase access to healthcare, particularly for minor ailments that do not require a physician's consultation.
Contention
While the bill aims to enhance healthcare access, it may raise concerns around the quality of care and the training of pharmacists in managing these health conditions. Critics may argue that such responsibilities should remain with medical doctors or advanced practice providers, particularly for conditions that may require more comprehensive medical evaluations. Additionally, concerns may arise over the standards of training required for pharmacists to perform these tasks effectively, and whether adequate safeguards are in place to protect patients while allowing pharmacists to operate within this expanded scope.
Relating to the regulation of pharmacists and the practice of pharmacy, including the administration of a medication and the ordering and administration of an immunization or vaccination by a pharmacist.